Literature DB >> 354443

Central hypoventilation syndrome: experience with bilateral phrenic nerve pacing in 3 neonates.

C E Hunt, S V Matalon, T R Thompson, S Demuth, J M Loew, H M Liu, A Mastri, B Burke.   

Abstract

Successful long-term phrenic nerve pacing has been reported in adults with acquired central hypoventilation syndrome. This report summarizes our experience with phrenic nerve pacing in 3 infants with congenital central hypoventilation syndrome. The electrodes were implanted in the lower thoracic portion of each phrenic nerve. In all patients. bilateral simultaneous pacing was required to maintain an adequate arterial PO2, tidal volume, and minute ventilation during quiet sleep. Case 1 died of problems primarily related to the severe cor pulmonale that had been present before pacemaker insertion; at autopsy, the pacemaker system was intact and there were no significant phrenic nerve abnormalities. Case 2 later developed failure of awake ventilatory control and died because of extensive phrenic nerve damage incurred by 19 days of continuous pacing. Case 3 has received quiet sleep pacemaker support since September 1977 and has been able to maintain normal quiet sleep ventilation in this manner. Phrenic nerve pacing can be successful in infants as long as continuous pacing is not required. Bilateral simultaneous pacing appears to be an appropriate alternative to home-based intermittent positive-pressure breathing for long-term management of children with central hypoventilation syndrome.

Entities:  

Mesh:

Year:  1978        PMID: 354443     DOI: 10.1164/arrd.1978.118.1.23

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

1.  Long-term implantation of platinum electrodes: effects on electrode material and nerve tissue.

Authors:  A Jonzon; E N Larsson; P A Oberg; G Sedin
Journal:  Med Biol Eng Comput       Date:  1988-11       Impact factor: 2.602

2.  Congenital central alveolar hypoventilation (Ondine's curse): a case report and review of the literature.

Authors:  F Yasuma; H Nomura; I Sotobata; H Ishihara; H Saito; K Yasuura; H Okamoto; S Hirose; T Abe; A Seki
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

3.  Continuous respiratory support in quadriplegic children by bilateral phrenic nerve stimulation.

Authors:  H Garrido; J Mazaira; P Gutierrez; E Gonzalez; J Rivas; J Madrazo
Journal:  Thorax       Date:  1987-08       Impact factor: 9.139

Review 4.  Congenital central hypoventilation syndrome and Hirschsprung's disease.

Authors:  G D Croaker; E Shi; E Simpson; T Cartmill; D T Cass
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

Review 5.  Congenital central hypoventilation syndrome: a bedside-to-bench success story for advancing early diagnosis and treatment and improved survival and quality of life.

Authors:  Debra E Weese-Mayer; Casey M Rand; Amy Zhou; Michael S Carroll; Carl E Hunt
Journal:  Pediatr Res       Date:  2016-09-27       Impact factor: 3.756

6.  Alveolar hypoventilation treated with medroxyprogesterone.

Authors:  J Milerad; H Lagercrantz; O Löfgren
Journal:  Arch Dis Child       Date:  1985-02       Impact factor: 3.791

7.  Negative extrathoracic pressure ventilation in central hypoventilation syndrome.

Authors:  H Hartmann; M H Jawad; J Noyes; M P Samuels; D P Southall
Journal:  Arch Dis Child       Date:  1994-05       Impact factor: 3.791

8.  Characteristics and surgical management of respiratory complications accompanying pathologic lesions of the brain stem.

Authors:  W W Glenn; B Haak; C Sasaki; J Kirchner
Journal:  Ann Surg       Date:  1980-06       Impact factor: 12.969

9.  Hirschsprung's disease, Ondine's curse, and neuroblastoma--manifestations of neurocristopathy.

Authors:  J E Roshkow; J O Haller; W E Berdon; S M Sane
Journal:  Pediatr Radiol       Date:  1988

10.  Abnormalities of breathing control and airway maintenance in infants and children as a cause of cor pulmonale.

Authors:  C E Hunt; R T Brouillette
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.